Generic Name:prasugrel Brand Name:Effient Drug Class:Antiplatelet Agents, Cardiovascular; Antiplatelet Agents, Hematologic What is prasugrel, and what is it used for? Prasugrel is a medication used during the treatment of patients with acute coronary syndrome (ACS),which includes two types ofheart at...
Considering the 1-year outpatient setting and a widespread generic PRG 10mg adoption, NHS savings are estimated in 898 323.59€, and patient savings in 401248.25€ (198.38€ per patient). CONCLUSIONS. ACS pts in real-world scenarios exhibit both eligibility for PRG and TCG. Considering the lower...
Prasugrel (Effient) - Uses, Side Effects, and More Medically Reviewed by Beth Johnston, PharmD, BCPS on Aug 01, 2024 | Written by Adam VanWert, PharmD, PhD Common Brand Name(s): Effient Common Generic Name(s): prasugrel Pronunciation: EF-fee-ent Drug Classes: antiplatelet agent Availabil...
公司简介 We are proud that since Teva’s establishment in 1901, healthcare providers together with patients and caregivers have been using our accessible generic and innovative products. Today, our portfolio of around 3,500 products is among the largest of any pharmaceutical company in the world....
Common Generic Name(s):prasugrel Pronunciation:EF-fee-ent Drug Classes:antiplatelet agent Availability:prescription only How is it used?tablet that is swallowed Uses What is prasugrel used for? Prasugrel is commonly used to lower the risk of having a heart attack or other serious problem with you...
Effient is available in both brand and generic versions. It is covered by most Medicare and insurance plans, but some manufacturer and pharmacy coupons can still help offset the cost. Get Prasugrel for as low as $25.20, save up to 80% off the average retail price for the most common ...
Effient (prasugrel) is an antiplatelet drug that prevents the platelets in the bloodstream from aggregating and formingblood clots, used to prevent blood clots in people with acute coronary syndrome who are undergoing a procedure after a recentheart attackorstroke, and in people with certain disorder...
Bioequivalence studies are performed to obtain marketing authorization for generic medicinal products. Assessment of bioequivalence is usually performed af... PJ Rudzki,M Filist,Katarzyna Bu-Kwanik - 《Farmacja Polska》 被引量: 0发表: 2016年 [Everything about prasugrel in the management of acute co...
At possible lower prices for generic clopidogrelbased therapy, the cost-effectiveness ratio for prasugrel-based therapy compared with clopidogrel-based therapy was between $6643 and $13,906 per life-year gained. The results were most sensitive to the relative costs of the two treatments and the ...
Phenotype-driven selection of ticagrelor or prasugrel is a cost-effective strategy compared with universal generic clopidogrel when added to aspirin as dual antiplatelet treatment to prevent repeat vascular events in patients with acute coronary syndrome (ACS), according to research presented at the 2013...